Pluri Inc. (PLUR:NASDAQ) closed at $1.05 on November 13, 2026, down 3.67% on the day. The stock trades 75.5% below its 52-week high of $4.29 and 23.5% above its 52-week low of $0.850. Over the past year, it lost 71.2%. Pluri Inc. is part of the Health Care sector.
In 252 trading sessions since November 13, 2025, PLUR closed higher on 103 days (41%). Its best day was October 21, 2026 (+16.67%) and its worst was May 19, 2026 (-19.23%). The stock moved 10% or more in a single session 12 times. It opened at least 5% above the previous day's high 5 times.
Pluristem Therapeutics Inc is a US-based company that acts as a developer of placenta-based cell therapy product candidates for the treatment of multiple ischemic, inflammatory, and hematologic conditions. The lead indications are critical limb ischemia, recovery after surgery for femoral neck fracture, and acute radiation syndrome. The company operations are focused on the research, development, clinical trials, and manufacturing of cell therapeutics and related technologies.
Find more stocks like PLUR with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.